Calidi Biotherapeutics, Inc. — SCHEDULE 13D Filings
2 SCHEDULE 13D filings on record
This page lists all SCHEDULE 13D filings submitted to the SEC by Calidi Biotherapeutics, Inc. (CLDWW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Calidi Biotherapeutics, Inc. has filed 2 SCHEDULE 13D documents with the SEC since 2021. To view all SEC filings by Calidi Biotherapeutics, Inc., see the full filings list.
All
10-K
10-Q
25
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D | — | 0002109116-26-000003 | Mar 9, 2026 | — |
| SCHEDULE 13D | — | 0002021677-24-000001 | May 1, 2024 | — |